Targeted Therapies Forum Presented in English 2023 - Q&A Video Series 2

Article and Video CATEGORIES

Cancer Journey

ABOUT

Sandip Patel, MD, is a board-certified medical oncologist who specializes in cancer immunotherapy and early phase clinical trials involving immunotherapy across all types of cancer. Dr. Patel is focused on developing personalized therapies that stimulate a patient’s immune system to attack their specific tumor. He believes in offering these promising immunotherapeutics across all tumor types.

Targeted Therapies Forum Presented in English 2023 - Q&A Video Series 2

AlexandraGBeneke

Wed, 10/04/2023 - 20:22

Our Targeted Therapies Forum online event includes a Q&A session where our amazing faculty answers questions from the audience. This is the second batch of videos for our Q&A session.

Author

Sandip P. Patel, MD, GRACE Faculty

Targeted Therapies Forum presented in English

In this series of videos from the Q&A sessions, the following videos are available for viewing:

Q&A: Should Biomarker Testing Be Performed on Patients with Squamous Cell Carcinoma?
Resistance on Targeted Therapy: Questions Patients Should Ask
What Are Some Local Therapy Options for Patients with NSCLC?
Q&A: What Can Patients Do to Close the Biomarker Testing Gap?
Q&A: What Do We Know About Prevention and Causes of Lung Cancer?

To watch the complete playlist click here.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Next Previous link

Previous Post Next Post

Article

The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.